SecBot SecBot
3 ·Filed Oct 27, 2026

BOLT

Bolt Biotherapeutics, Inc.
NEUTRAL
Impact 2/10
Processed4h 20m ago SEC0001193125-26-434466
Form 3 — initial insider ownership statement

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001193125-26-434466
Document: 0001193125-26-434466-index-headers.html0001193125-26-434466
Document: 0001193125-26-434466-index.html0001193125-26-434466
Document: 0001193125-26-434466.txt0001193125-26-434466
6 reports for BOLT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for BOLT — sortable, filterable
TypeNow
Oct 27, 2026
today
3
NEUTRAL ★ 2/10
$6.58awaiting T+5—$6.37 (−3.19%)
Oct 23, 2026
4d ago
8-K
MIXED ★ 7/10
$6.27awaiting T+5—$6.37 (+1.59%)
Oct 6, 2026
21d ago
8-K
BEARISH ★ 6/10
$3.60 $3.98▼ −10.56%▼ −11.54%$6.37 (−76.94%)
May 12, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$4.83 $4.72▼ −2.28%▼ −1.12%$6.37 (+31.88%)
May 12, 2026
24w ago
Press Release
BEARISH ★ 7/10
$4.83 $4.72▲ +2.28%▲ +1.12%$6.37 (−31.88%)
Mar 12, 2026
32w ago
Press Release
MIXED ★ 5/10
$3.91 $4.76▲ +21.74%▲ +23.86%$6.37 (+62.92%)
Showing 6 of 6

US Market Status

Market Closed — Opens Thu (11h 49m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 27, 2026

Fresh BOLT Intelligence

Analysis is for subscribers only.

Subscribe for Full Access